Eri Taguchi

KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties.

Yasunari Fujiwara, Nicolas Guilbaud, M. Shibuya, 2006, Cancer research.

One-Step Conjugation Method for Site-Specific Antibody-Drug Conjugates through Reactive Cysteine-Engineered Antibodies.

Kazuhiro Masuda, Tsuyoshi Yamaguchi, Eri Taguchi, 2016, Bioconjugate chemistry.